Skip to main content

Home/ health information/ Group items tagged leadership-in-pharmacy

Rss Feed Group items tagged

pharmacybiz

Pete Kelly : Accord managing director is new chair at BGMA - 0 views

  •  
    he British Generic Manufacturers Association (BGMA) has voted Pete Kelly, managing director of Accord UK, to become its new chair. He replaces Peter Ballard, who has completed his second tenure as the association's chair and will now serve a further year as vice-chair. Pete leads the UK operations of Accord, one of the largest generic and biosimilar manufacturers in Europe. In the UK, the company currently supplies a fifth of all generic medicines. Mark Samuels, chief executive of BGMA, said: "We are very fortunate to have someone of Pete's experience and leadership qualities to take on the mantle of chair of the association. The industry faces a challenging period on many fronts, and Pete's input will be invaluable. "I would also like to record my enormous gratitude to Peter Ballard, our out-going Chair who has been an incredible servant to the association over many, many years. He will continue for another year as vice-chair, and we are pleased to have his continuing advice."
pharmacybiz

Michael Matheson:Cabinet Secretary NHS Health,Social Care - 0 views

  •  
    The Royal Pharmaceutical Society (RPS) has welcomed the appointment of Michael Matheson MSP as Cabinet Secretary for NHS Recovery, Health and Social Care in Scotland. Commenting on the announcement Laura Wilson, Director of RPS Scotland, said: "I would like to congratulate Michael Matheson on being appointed to this position. NHS recovery is vitally important, and pharmacy has a huge amount to offer this agenda. "Our current priorities include enabling pharmacists to take leadership of prescribing in all care settings, tackling health inequalities and advocating for change, implementing shared patient records between healthcare professionals to provide high-quality, person centred and safe patient care, improving pharmacists' wellbeing and tackling the climate emergency by encouraging sustainable and green prescribing across Scotland.
pharmacybiz

David Wright : HRA Pharma CEO resignation - 0 views

  •  
    HRA pharma has announced the resignation of David Wright who moves on after serving the company for more than five years as chief executive officer. The company has appointed Martyn Hilton, chief commercial officer for HRA Pharma, as interim CEO effective from September 1, 2022. David helmed the company during a period of transformation and set the course for its tremendous growth, elevating HRA Pharma into a leading provider of over-the-counter self-care products. He commented: "Given the significant progress HRA has made, along with my personal goals after leading HRA for more than five years, I believe now is the time to step away from the business. "I am proud of all that we have accomplished, making HRA well-known for its Women's Health, Wound Care and Scar Care leadership, operating via brands including ellaOne, Hana, Compeed and Mederma. I appreciate all the team members involved in the success of the organization and believe Perrigo and HRA are well-positioned to elevate this business and these brands to the next level."
pharmacybiz

Alliance Healthcare UK appoints Marie Evans as new managing director - 0 views

  •  
    Alliance Healthcare, the UK's largest pharmaceutical wholesaler, announced today (December 7) the appointment of Marie Evans as its new managing director. Evans, who is the current commercial and category director of the firm, will report to Juan Guerra, Alliance Healthcare's senior vice president and managing director of International Wholesale. Commenting on the new appointment, Guerra said: "The last 18 months has shown just how important wholesale and distribution is to the NHS and I am so excited to welcome Marie to her new position at this critical time. "Her experience and leadership will be key as we continue to evolve our services in response to the changing needs of pharmacy, the health service, and industry."
pharmacybiz

Clare Morrison joins NHS Scotland in January - 0 views

  •  
    The Royal Pharmaceutical Society (RPS) Director for Scotland, Clare Morrison will be joining NHS Scotland in January. Morrison has been appointed Director of Community Engagement at Healthcare Improvement Scotland. Paul Bennett, RPS CEO said: "Many people, particularly in Scotland, will know of Clare's passion for quality improvement and patient involvement in the co-design of services. This was demonstrated through her previous work on the development of Near Me, NHS Scotland's video consulting service, and its co-design with the public, patients, clinicians and NHS staff which gained international recognition from the Institute for Healthcare Improvement. "Therefore, this is an exciting opportunity for Clare to join Healthcare Improvement Scotland to take on a strategic leadership role in supporting effective community engagement across health and social care in Scotland. It also enables Clare to make even greater use of her training as an NHS Scotland Scottish Quality & Safety Fellow and we wish her every success in her new role.
pharmacybiz

Diane DiGangi Trench: BGMA appoints its new vice-chair - 0 views

  •  
    The British Generic Manufacturers Association (BGMA) has elected Diane DiGangi Trench to be its new vice-chair. DiGangi Trench takes up the position replacing Xiromed's Peter Ballard and in 12-months' time will assume the association's chair role from Accord's Peter Kelly. With over 25 years of pharmaceutical industry experience, DiGangi Trench has held a number of senior commercial roles including stints with Takeda and Astra Zeneca. She joined Sandoz in 2018 in the US, where she served as Vice-President, Market Access and Patient Services. In 2021, she became the head of Sandoz' UK business and in her two years in role, she has led the organisation through a post-COVID recovery and growth phase to prepare for the proposed spin out of the company from its parent, Novartis, expected later this year. She said: "It's a great honor to take on the role of Vice Chair of the BGMA. The success of the generics and biosimilar industry is essential to the functioning of the NHS. Generic medicines fill four out of five UK prescriptions and biosimilars enable the NHS to expand access to more patients. I am passionate about increasing the sustainability of our industry so we can continue to play our vital part in the health of the nation." Mark Samuels, BGMA chief executive, said: "We are extremely fortunate to be able to call upon the expertise of Diane who has already added significant value through her role on the BGMA board and leadership of a key strategic committee.
pharmacybiz

National Self-Care Strategy:Pharmacists in England supports - 0 views

  •  
    A new report based on research from pharmacists across England by Sanofi, has called for the introduction of a 'national self-care strategy' to relieve the burden currently faced by health services. The new report, titled 'Driving a self-care revolution in the UK', explores the views of pharmacists, patients and doctors on self-care and the support needed to deliver it more effectively. While self-care policy measures are estimated to increase monetary savings for healthcare systems and national economies by 16%, this report highlights the right tools and resources are not yet in place to enable pharmacists to play a greater role in delivering self-care advice and medicines to patients. "As many as 77% of pharmacists said they would support the creation of a National Self-Care Strategy to provide national leadership on improving understanding of self-care and encourage its use among both patients and clinicians," the report said. According to the report, currently, 33% of pharmacists working for independent or small pharmacy chains do not have the resources to support patients with self-care, alongside their other roles. "To tackle this, close to half (45%) of pharmacists believe greater emphasis by primary care practitioners on the benefits of self-care would leave pharmacists in a better place to support patients. Similarly, 42% believe that training and recruiting more pharmacists would improve their capacity to deliver self-care advice."
pharmacybiz

https://www.pharmacy.biz/steve-barclay-appointed-as-new-health-secretary/ - 0 views

  •  
    Boris Johnson has picked Steve Barclay as the new health secretary following the resignation of Sajid Javid, who stepped down on July 5 after saying he had lost faith in prime minister's leadership. Barclay - who had served as chief of staff of the prime minister since February 2022 - was previously a junior health minister in 2018, responsible for NHS workforce and finance, before serving as Brexit secretary, chief secretary to the Treasury, and chancellor of the duchy. He is the fourth health secretary after Jeremy Hunt, Matt Hancock and Sajid Javid in the past five years. In a statement on his appointment, Barclay said it was "an honour" to be take up the position, adding: "Our NHS and social care staff have showed us time and again - throughout the pandemic and beyond - what it means to work with compassion and dedication to transform lives. "This government is investing more than ever before in our NHS and care services to beat the Covid-19 backlogs, recruit 50,000 more nurses, reform social care and ensure patients across the country can access the care they need."
pharmacybiz

Roger Scarlett-Smith steps down as head of STADA UK - 0 views

  •  
    In a mutual agreement with the STADA board, Roger Scarlett-Smith has stepped down from his role as head of UK. The company has assigned the responsibility of UK operation to Rudolf Bär with current responsibilities as cluster head for Mid-Sized European Markets. Scarlett-Smith joined STADA in October 2018 to lead the UK operation upon the retirement of Dieno George. Prior to this, he had enjoyed an illustrious career in the Consumer Healthcare sector, largely with GlaxoSmithKline, for which he held positions including as President North America, President EMEA and Head of Global Categories. Under his leadership, the STADA UK business has grown sales by 50 per cent and profitability has more than doubled. He has reshaped the business to improve efficiency. There has been a marked acceleration of product innovation including key line extensions to the Zoflora disinfectant range as well as the introduction of a salmeterol and fluticasone inhaler in the Rx respiratory sector. Meanwhile, T+R has developed a fine reputation regionally, being voted number 1 regional company last year and winning many national industry awards.
pharmacybiz

ABPI welcomes NICE's guidance on value of new antibiotics - 0 views

  •  
    The Association of the British Pharmaceutical Industry (ABPI) has welcomed the National Institute for Health and Care Excellence's leadership in introducing a new approach to the evaluation of antibiotics. On Tuesday (12 April), NICE published a draft guidance to tackle antimicrobial resistance under which two new antimicrobial drugs - cefiderocol and ceftazidime-avibactam - became the first to be made available as part of the UK's innovative subscription-style payment model. Commenting on the announcement of the new draft guidance, Richard Torbett, chief executive of the ABPI, said: "This is an important milestone in the UK's global leadership on AMR. Antibiotics underpin modern medicine, but the increasing threat of antibiotic resistance remains one of the biggest global health challenges we face. "To tackle this, it is critical that the appropriate frameworks are in place for companies to invest the billions of pounds required to discover the new antibiotics needed for patients.
pharmacybiz

RPS publishes new core advanced pharmacist curriculum - 0 views

  •  
    The Royal Pharmaceutical Society (RPS) has published its new 'Core Advanced Pharmacist Curriculum' to enable professional development towards advanced pharmacist practice. This follows an intensive programme of work undertaken in collaboration with a wide range of UK stakeholders, the society said today (June 27) in a statement. The Curriculum will equip pharmacists with advanced leadership, education, and research capabilities which are essential to support, lead and advance the profession through transformative change so it continues to meet evolving patient and service requirements. The RPS Core Advanced Curriculum provides the blueprint to develop such individuals by articulating a UK entry-level standard to advanced pharmacist practice, relevant to all patient-focussed pharmacist roles and aligned to multi-professional definitions of advanced practice. This curriculum completes the core RPS post-registration curricula, creating a seamless post-registration professional development continuum modelled around five common domains- Person-centred care and collaboration; Professional practice; Leadership and management; Education; and Research.
pharmacybiz

Rosalind Brewer Resigns as CEO of Walgreens Boots Alliance - 0 views

  •  
    Rosalind Brewer, the CEO of Walgreens Boots Alliance, Inc. (WBA), the parent company of Boots UK, has resigned from her position after serving for less than three years. The prominent US pharmaceutical company is currently in the process of searching for her successor. Ginger Graham, the lead independent director, has been appointed as the interim CEO. "WBA's board of directors and Brewer have mutually agreed on her departure as chief executive and board member," the company said in a statement. Brewer officially stepped down from her roles as chief executive and director on Thursday (Aug. 31). She assumed the CEO role in March 2021, succeeding Executive Chairman Stefano Pessina. Prior to this, Brewer held the position of CEO at Starbucks. The leadership change aligns with WBA's shift towards becoming a broader healthcare company, a strategic move initiated by Brewer and her team in October 2021.
pharmacybiz

Big News :Boots Sebastian James to Step Down as Managing Director - 0 views

  •  
    Walgreens Boots Alliance (WBA) has officially announced that Sebastian James, the Managing Director of Boots, will be stepping down from his role to pursue a new opportunity in the healthcare sector. James has given notice to leave the company and will remain with Boots until November. The UK pharmacy giant has already begun the search for a new Managing Director. James is set to take on the role of CEO at Veonet, a leading European chain of ophthalmology clinics. During his tenure as Managing Director since 2018, James played a pivotal role in transforming Boots into the UK's leading health and beauty retailer. He oversaw significant growth and innovation, achieving thirteen consecutive quarters of retail market share growth. Most recently, the company announced strong Q3 results in June with growth across all categories.
pharmacybiz

Kasper Künzel:Interim VP,GM of Leo Pharma UK and Ireland - 0 views

  •  
    Leo Pharma, one of the leaders in medical dermatology, has appointed Kasper Künzel as Interim Vice President and General Manager for its UK and Ireland business. Kasper is an established leader within Leo Pharma, having previously been Vice President, IPO Preparedness Office, at Leo Pharma in Denmark. Kasper brings over 17 years of pharmaceutical experience, previously taking on local and global leadership positions across Leo Pharma in functions including R&D, Finance and Commercial. Having first joined Leo Pharma in Denmark in a financial function, his previous roles include General Manager in South Korea, Vice President of Corporate Transformation, and Director of R&D Business Finance He commented: "I am delighted to join the Leo Pharma UK and Ireland team and continue to build on the company's strong heritage in these markets. The UK and Ireland team are committed to the Leo Pharma values as a leader in medical dermatology, and I'm looking forward to all we can achieve together this year.
pharmacybiz

AMR research : Government allocates £39 million - 0 views

  •  
    The government has launched the Global AMR Innovation Fund (GAMRIF) on Monday (22 May), under which it has announce up to £39 million fund for antimicrobial resistance (AMR) research. Of this new funding package, up to £24 million over four years has been awarded to bolster the UK's partnership with CARB-X - a global AMR research initiative - to support the continued early development of invaluable new antibiotics, vaccines, rapid diagnostics and other products to combat life threatening drug-resistant infections and prevent death and disease across the world. In addition to the CARB-X grant, GAMRIF is investing £5 million over two years into the Global Antibiotic R&D Partnership (GARDP) to develop - and ensure global access to - new antibiotic treatments against major global health priorities. The announcement comes as Health Minister Will Quince attends the World Health Assembly (WHA) in Geneva, Switzerland, and Development Minister Andrew Mitchell participates in an event on health leadership and climate change alongside the WHA. They will announce the launch of the UK government's Global Health Framework for 2023-2025, as part of Minister Quince's address at the WHA. Health Minister Will Quince said: Antimicrobial resistance is a major threat to global health and has led to millions of tragic deaths per year, but the Global AMR Innovation Fund is supporting cutting-edge research and developing vital new treatments to prevent death and disease across the world.
pharmacybiz

Kamila Hawthorne Receives GG2 Woman of the Year Award - 0 views

  •  
    Kamila Hawthorne, the chair of the Royal College of General Practitioners (RCGP) Council, was honoured with the GG2 Woman of the Year Award at the annual GG2 Leadership and Diversity Awards, held at the Park Plaza Hotel on Tuesday, 5 March. Hawthorne has been a practitioner and a mentor to young GPs for almost 35 years, and has led pioneering research projects focusing on health inequalities, diabetes and heart disease. She has been recognised twice as GP of the Year for her work with minority ethnic communities. Professor Kiran Patel, Group Chief Medical Officer at University Hospitals Birmingham NHS Foundation Trust, was named the GG2 Man of the Year Award. Apart from being a sought-after cardiologist and consultant, Patel also possesses a wealth of experience in managerial roles. He has done a lot of work in addressing health inequalities, and notably, in 2020, he prescribed the very first COVID-19 vaccine.
pharmacybiz

Brian R. Fischel : PAGB Vice President UK - 0 views

  •  
    PAGB, the prominent consumer healthcare association, has appointed a new Vice-President following the departure of Richard Holme from PAGB's Board earlier this year. Brian R. Fischel, who currently serves as Regional Director & General Manager for UK and Ireland at Reckitt, is set to take on the new Vice-President role at PAGB. Bringing extensive international experience as Vice-President at UK trade association representing manufacturers of branded over-the-counter medicines, medical devices and food supplements, Fischel has over eight years at Reckitt managing various global health territories. His election in the leadership role in June positions him alongside Bas Vorsteveld, President, and Mike Knowland, Vice President, completing PAGB's executive team. Michelle Riddalls, CEO of PAGB, expressed optimism about Brian's appointment, emphasising his alignment with PAGB's strategic objectives.
pharmacybiz

Pinder Sahota:ABPI President decided to step down - 0 views

  •  
    The Association of the British Pharmaceutical Industry (ABPI) has announced that Pinder Sahota has decided to step down as President of the ABPI. ABPI stated that he has made this decision to "avoid an ongoing process around a Novo Nordisk ABPI Code of Practice breach becoming a distraction from the vital work of the ABPI". Richard Torbett, Chief Executive, ABPI, said: "Pinder is a passionate advocate for the industry, and I want to thank him for his valuable contribution as ABPI President. "I fully respect Pinder's decision to step down as ABPI President which will in no way affect the ongoing case relating to Novo Nordisk. Any breach of the ABPI Code is taken extremely seriously and it is essential that all regulatory actions are robust, fair and transparent." ABPI Vice-President, Susan Rienow, Country President of Pfizer, will temporarily take on the roles and responsibilities of the ABPI President until a new President is chosen by the ABPI Board.
pharmacybiz

DHSC New NIHR RDN Transforming UK Research - 0 views

  •  
    The Department of Health and Social Care (DHSC) has created a new NIHR Research Delivery Network (RDN) to support the successful delivery of health and social care research in England. The network, which will start operating from next year, will play a critical and active role in implementing government policies. It will support in implementing the Life Sciences Vision, the Future of UK Clinical Research Delivery vision, and policy for life sciences research and development. The new network would be mainly working on growing the amount of commercial clinical research as its key strategic ambition. Also, NIHR RDN will be responding to the findings of the Lord O'Shaughnessy review, which set out a clear blueprint for how the UK can return to its global leadership role.
pharmacybiz

Rishi Sunak:Become first British Asian PM on Diwali Day - 0 views

  •  
    Former chancellor Rishi Sunak on Monday (October 24) won the battle for leader of Britain's Conservative party and will become the country's first prime minister of colour. Penny Mordaunt, the last rival left after Boris Johnson dramatically pulled out, failed to secure the necessary 100 nominations from her fellow MPs. "Rishi Sunak is therefore elected as leader of the Conservative party," senior backbencher Graham Brady said, as Mordaunt pledged her "full support" for Sunak. Sunak's triumph came after Johnson's decision late Sunday to abandon his political comeback bid. Just weeks after he lost out to Liz Truss to lead the ruling Tories, Sunak therefore pulled off a stunning reversal in fortunes. The contest, triggered by outgoing leader Truss's resignation on Thursday, had required candidates to secure the support of at least 100 Conservative MPs by 2:00 pm (1300 GMT) on Monday.
« First ‹ Previous 61 - 80 of 81 Next ›
Showing 20 items per page